Crazy idea - Forget all about Brilacidin for the moment and let's just talk about Kevetrin.

Kevetrin has been dead in the water for years due to lack of funds to finish tox tests on the oral version (pill). From news a number of years ago about 1/2 of the tests had been finished.

Realistically, how much can the balance cost? When one realizes K showed very promising results for lymphoma (think that's what it was) at the U of Bologna in Italy and in conjunction with some other cancer treatment in the USA provided the only known remission in renal cancer and the Cancer Foundation makes many, many billions a year to fund cancer research it is beyond me why K hasn't moved forward.

One would think some BP would take a flyer to get this pill finished and authorized to be used in a multitude of trials as a complementary aid to other current treatments such as was done with the renal cancer drug.

I am just trying to consider ways we could get things moving forward instead of seeming to be in a hover mode.

The potential for K in cancer is so large let's get some deal made that would profit IPIX and the BP. Win-Win.